You are here: Industry Insights > Recipharm

News List

Recipharm, SERB Enter Agreement contractpharma
June 19, 2018
Recipharm has signed and closed an agreement with SERB SA (“SERB”) on a divestment of its rights to its potassium iodide product ThyroSafe® except for the US territory.
Recipharm Acquires Sanofi’s UK CMO Biz contractpharma
June 19, 2018
Recipharm has acquired Sanofi’s manufacturing center and business in Holmes Chapel, UK, expanding its inhalation capabilities in the growing respiratory drug market with commercial drug product manufacturing.
Recipharm to buy Sanofi inhalation contract business and plant in U.K. for $60M fiercepharma
June 14, 2018
Recipharm has struck a deal with Sanofi to buy the French drugmaker’s contract inhalation drug business and plant in the U.K., picking up new capabilities and clients in the process.
Recipharm and Roche sign agreement to manufacture solid dose products pharmaceufical-technology
September 22, 2017
Swedish pharmaceutical company Recipharm has signed a long-term manufacturing agreement with Roche to produce a wide range of solid dose products.
Recipharm and LIDDS set up prostate cancer drug development facility in Sweden pharmaceutical-technology
July 25, 2017
Recipharm, a Swedish contract development and manufacturing organisation (CDMO), and LIDDS have jointly established an industrial manufacturing line to develop new prostate cancer drug, Liproca Depot.
Recipharm and LIDDS establish industrial manufacturing capabilities for a novel prostate cancer prod cphi-online
July 21, 2017
GMP Manufacturing line industrialised according to a unique process invented by LIDDS, involving the installation of novel equipment that is new to the pharmaceutical industry.
Recipharm, LIDDS Establish Industrial Manufacturing Capabilities for Novel Prostate Cancer Product americanpharmaceuticalreview
July 21, 2017
Recipharm and LIDDS have set up a manufacturing line for LIDDS’ novel prostate cancer drug, Liproca Depot, at Recipharm in Solna, Sweden.
Recipharm Makes Appointment in the UK & Ireland contractpharma
May 27, 2017
Recipharm has invested in its UK and Ireland presence with the appointment of Shabbir Mostafa to its business management team.
Recipharm delivers first serialised batch to Saudi Arabia cphi-online
April 25, 2017
Company has invested €300,000 into the project, which is part of a wider €40 million investment into new serialisation technology and processes to comply with the European Falsified Medicines Directive.
Recipharm Bolsters Executive Team contractpharma
April 14, 2017
Recipharm AB has appointed Henrik Stenqvist as its new executive vice president and chief financial officer, effective on April 24, 2017. He will be based at the company’s headquarters in Stockholm, Sweden and reports to Thomas Eldered, chief executive of

Previous page 1 2 3 4 5 Next page